lysine has been researched along with Cardiovascular Diseases in 48 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (4.17) | 18.2507 |
| 2000's | 17 (35.42) | 29.6817 |
| 2010's | 22 (45.83) | 24.3611 |
| 2020's | 7 (14.58) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Du, C; Lu, W; Qi, Y; Su, Q; Wang, Q; Wang, X; Wu, H; Yuan, H; Zhang, Z | 1 |
| Bakker, SJL; Baskal, S; Bollenbach, A; Kremer, D; Post, A; Tsikas, D | 1 |
| Archer, KJ; Cousin, L; Garrett, T; Kelly, DL; Lyon, DE; Yao, Y | 1 |
| Barg, E; Bodetko, A; Hetman, M; Mielko, K; Młynarz, P; Placzkowska, S | 1 |
| Lutgens, E | 1 |
| Alonso-Gómez, A; Clish, CB; Corella, D; Dennis, C; Estruch, R; Fitó, M; Gómez-Gracia, E; Guasch-Ferré, M; Hu, FB; Lapetra, J; Li, J; Liang, L; Martínez-González, MA; Pierce, KA; Razquin, C; Romaguera, D; Ros, E; Ruiz-Canela, M; Salas-Huetos, A; Salas-Salvadó, J; Serra-Majem, L; Toledo, E | 1 |
| Ren, J; Yang, M; Zhang, Y | 1 |
| von Eckardstein, A | 1 |
| Singh, SA; Srinivasan, K; Venkatesh, R | 1 |
| Allayee, H; Buffa, JA; Cajka, T; DiDonato, JA; Fiehn, O; Gu, X; Han, Y; Hartiala, JA; Hazen, SL; Hurd, AG; Kerby, RL; Li, L; Li, XS; Lüscher, TF; Nemet, I; Obeid, S; Rey, FE; Roberts, AB; Romano, KA; Shahen, CJ; Skye, SM; Tang, WHW; Wagner, MA; Wang, Z; Wu, Y | 1 |
| Nakaya, I; Nakayama, K; Nakayama, M; Soma, J; Tezuka, Y; Yahata, M | 1 |
| Schiattarella, GG; Trimarco, B | 1 |
| Ge, J; Li, H; Li, P | 1 |
| Auge, D; Chafai, A; Fromm, MF; Gessner, A; Maas, R; Mieth, M; Müller, F | 1 |
| Dekker, JM; Engelen, L; Ferreira, I; Hanssen, NM; Huijberts, MS; Nijpels, G; Schalkwijk, CG; Scheijen, JL; Stehouwer, CD; van der Kallen, CJ; van Greevenbroek, MM | 1 |
| Arnold, AM; Djousse, L; Hirsch, C; Ix, JH; Kizer, JR; Mukamal, KJ; Newman, AB; Siscovick, D; Thielke, SM; Tracy, RP; Whitson, HE; Yee, LM; Zieman, S | 1 |
| Antonini, SR; Barbieri, MA; Bettiol, H; Bueno, AC; de Castro, M; Elias Junior, J; Foss-Freitas, MC; Martins, CS; Miranda, W; Scherer, PE; Sun, K; Tao, C | 1 |
| Meslamani, J; Sanchez, R; Zhou, MM | 1 |
| Arnold, AM; Benkeser, D; Djousse, L; Ix, JH; Kizer, JR; Mukamal, KJ; Psaty, BM; Siscovick, DS; Tracy, RP; Zieman, SJ | 1 |
| Chen, Y; Cui, L; Cui, Z; Li, M; Shang, R; Sun, Y; Xu, F | 1 |
| Dunne, K; Flashman, E; Hancock, RL; Kawamura, A; Walport, LJ | 1 |
| Ferrucci, L; Garcia, M; Harris, TB; Newman, AB; Satterfield, S; Schwartz, AV; Semba, RD; Sun, K; Varadhan, R | 1 |
| Cleary, PA; Gao, X; Genuth, S; Lachin, JM; Monnier, VM; Sell, DR; Sun, W | 1 |
| Dagnelie, PC; Henry, RM; Koster, A; Kroon, AA; Schalkwijk, CG; Schaper, N; Scheijen, J; Schram, MT; Sep, SJ; Smit, AJ; Stehouwer, CD; van der Kallen, CJ; van Eupen, MG; van Sloten, TT | 1 |
| Davies, SS | 1 |
| Beck, J; Dalal, M; Ferrucci, L; Fried, LP; Guralnik, JM; Semba, RD; Sun, K; Varadhan, R; Walston, J | 1 |
| Brennan, DM; Cho, L; Hazen, SL; Tang, WH; Wang, Z | 1 |
| Kumar, U; Lin, G; MacLeod, KM; McNeill, JH; Nagareddy, PR; Rajput, PS; Soliman, H | 1 |
| Bandinelli, S; Ferrucci, L; Guralnik, JM; Semba, RD; Sun, K | 1 |
| Lu, Z; Sack, MN; Scott, I; Webster, BR | 1 |
| Cottin, Y; Ghibu, S; Richard, C; Rochette, L; Vergely, C; Zeller, M | 1 |
| Ai, M; Ausman, LM; Freed, A; Harding, SV; Jones, PJ; Kuvin, JT; Lichtenstein, AH; Matthan, NR; Otokozawa, S; Rideout, TC; Schaefer, EJ; Vega-López, S | 1 |
| Escobedo, JO; Lim, S; Samoei, GK; Sibrian-Vazquez, M; Strongin, RM | 1 |
| Brown, L; Fairlie, DP; Iyer, A | 1 |
| Fukasawa, H; Furuya, R; Hishida, A; Isobe, S; Kinoshita, N; Kumagai, H; Miyata, T | 1 |
| Inaba, M; Koyama, H; Nishizawa, Y | 1 |
| Busch, M; Franke, C; Franke, S; Müller, A; Niwa, T; Stein, G; Wendt, T | 1 |
| Anderstam, B; Bárány, P; Fehrman-Ekholm, I; Heimbürger, O; Lindholm, B; Pecoits-Filho, R; Qureshi, AR; Rodríguez Ayala, E; Stenvinkel, P; Suliman, ME | 1 |
| Braun, A; Busch, M; Fleck, C; Franke, S; Müller, A; Müller, UA; Schiel, R; Stein, G | 1 |
| Baliga, BS; Cai, W; Dardaine, V; Goldberg, T; Peppa, M; Uribarri, J; Vlassara, H | 1 |
| Aso, Y; Okumura, K; Yoshida, N | 1 |
| Csiky, B; Heidland, A; Laczy, B; Molnár, GA; Molnár, M; Nagy, J; Tamaskó, M; Wagner, L; Wagner, Z; Wittmann, I | 1 |
| Salzberg, DJ; Weir, MR | 1 |
| Busch, M; Franke, S; Stein, G; Wolf, G | 1 |
| Ischiropoulos, H; Rader, DJ | 1 |
| Buring, JE; Cheng, S; Erlich, HA; Lindpaintner, K; Ridker, PM; Rifai, N; Zee, RY | 1 |
| Flodin, NW | 1 |
| Miles, LA; Plow, EF | 1 |
14 review(s) available for lysine and Cardiovascular Diseases
| Article | Year |
|---|---|
The Function of SUMOylation and Its Critical Roles in Cardiovascular Diseases and Potential Clinical Implications.
Topics: Animals; Cardiovascular Diseases; Cysteine Endopeptidases; Heart; Humans; Lysine; Molecular Targeted Therapy; Organogenesis; Signal Transduction; Small Ubiquitin-Related Modifier Proteins; Sumoylation; Ubiquitin-Conjugating Enzymes | 2021 |
Acetylation in cardiovascular diseases: Molecular mechanisms and clinical implications.
Topics: Acetylation; Animals; Cardiovascular Diseases; Cell Differentiation; Diabetes Mellitus; Energy Metabolism; Histone Acetyltransferases; Histone Deacetylases; Histones; Humans; Lysine; Obesity; Protein Processing, Post-Translational; Reperfusion Injury | 2020 |
Lysine acetyltransferases and lysine deacetylases as targets for cardiovascular disease.
Topics: Acetylation; Animals; Cardiovascular Agents; Cardiovascular Diseases; Cardiovascular System; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Lysine; Lysine Acetyltransferases; Molecular Targeted Therapy; Protein Processing, Post-Translational; Signal Transduction | 2020 |
The bromodomain: from epigenome reader to druggable target.
Topics: Acetylation; Cardiovascular Diseases; Epigenesis, Genetic; Histones; HIV Infections; Humans; Lysine; Models, Molecular; Neoplasms; Protein Conformation; Protein Interaction Domains and Motifs; Protein Processing, Post-Translational; Protein Structure, Tertiary; Small Molecule Libraries; Transcription Factors | 2014 |
The Glu504Lys polymorphism of aldehyde dehydrogenase 2 contributes to development of coronary artery disease.
Topics: Aldehyde Dehydrogenase; Aldehyde Dehydrogenase, Mitochondrial; Alleles; Asian People; Cardiovascular Diseases; Coronary Artery Disease; Genetic Predisposition to Disease; Glutamic Acid; Humans; Inflammation; Lysine; Nitric Oxide Synthase Type III; Oxidative Stress; Polymorphism, Genetic; Risk Factors | 2014 |
Epigenetic regulation by histone demethylases in hypoxia.
Topics: Cardiovascular Diseases; Epigenesis, Genetic; Histones; Humans; Hypoxia; Jumonji Domain-Containing Histone Demethylases; Lysine; Methylation; Models, Genetic; Neoplasms | 2015 |
Modulation of protein function by isoketals and levuglandins.
Topics: Aldehydes; Amines; Animals; Cardiovascular Diseases; Cytotoxins; Dinoprostone; Humans; Ion Channels; Lipid Peroxidation; Lysine; Microtubules; Prostaglandins; Proteasome Inhibitors; Proteins; Pyridoxamine | 2008 |
The emerging characterization of lysine residue deacetylation on the modulation of mitochondrial function and cardiovascular biology.
Topics: Acetylation; Acetyltransferases; Animals; Apoptosis; Cardiovascular Diseases; Cardiovascular System; Cell Nucleus; Cytoplasm; Energy Metabolism; Humans; Lysine; Mitochondria; Mitochondria, Heart; Mitochondrial Proteins; NAD; Oxidation-Reduction; Oxidative Stress; Protein Processing, Post-Translational; Signal Transduction; Sirtuins | 2009 |
Antioxidant properties of an endogenous thiol: Alpha-lipoic acid, useful in the prevention of cardiovascular diseases.
Topics: Animals; Antioxidants; Cardiovascular Diseases; Diabetic Neuropathies; Dietary Supplements; Endothelium, Vascular; Humans; Lysine; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Molecular Structure; Reactive Oxygen Species; Thioctic Acid | 2009 |
Lysine acetylation in obesity, diabetes and metabolic disease.
Topics: Acetylation; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Energy Metabolism; Histone Acetyltransferases; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Lysine; Obesity | 2012 |
AGEs and cardiovascular diseases in patients with end-stage renal diseases.
Topics: Arginine; Atherosclerosis; Cardiovascular Diseases; Female; Glycation End Products, Advanced; Humans; Kidney Failure, Chronic; Lysine; Male; Oxidative Stress; Renal Dialysis; Risk Factors; Serum Albumin; Vascular Stiffness | 2012 |
COX-2 inhibitors and cardiovascular risk.
Topics: Blood Pressure; Cardiovascular Diseases; Cyclooxygenase 2 Inhibitors; Humans; Isoxazoles; Lactones; Lysine; Risk Factors; Sulfonamides; Sulfones; Water-Electrolyte Balance | 2007 |
The metabolic roles, pharmacology, and toxicology of lysine.
Topics: Animals; Cardiovascular Diseases; Cerebrovascular Disorders; Dietary Proteins; Herpes Simplex; Humans; Lysine; Nutritive Value; Osteoporosis; Recurrence; Ubiquitins | 1997 |
Lp(a): an interloper into the fibrinolytic system?
Topics: Amino Acid Sequence; Apolipoproteins A; Base Sequence; Binding, Competitive; Blood Proteins; Cardiovascular Diseases; Fibrin; Fibrinogen; Humans; Lectins, C-Type; Lipoprotein(a); Lipoproteins; Lysine; Molecular Sequence Data; Molecular Structure; Plasminogen; Plasminogen Activators; Protein Binding; Receptors, Cell Surface; Receptors, Urokinase Plasminogen Activator | 1990 |
3 trial(s) available for lysine and Cardiovascular Diseases
| Article | Year |
|---|---|
Urinary excretion of amino acids and their advanced glycation end-products (AGEs) in adult kidney transplant recipients with emphasis on lysine: furosine excretion is associated with cardiovascular and all-cause mortality.
Topics: Adult; Aged; Biomarkers; Cardiovascular Diseases; Female; Glycation End Products, Advanced; Humans; Kidney Transplantation; Lysine; Male; Middle Aged; Prospective Studies; Tissue Donors; Transplant Recipients; Young Adult | 2021 |
Skin collagen advanced glycation endproducts (AGEs) and the long-term progression of sub-clinical cardiovascular disease in type 1 diabetes.
Topics: Adult; Arginine; Asymptomatic Diseases; Biomarkers; Biopsy; Cardiovascular Diseases; Carotid Artery Diseases; Carotid Intima-Media Thickness; Chi-Square Distribution; Collagen; Coronary Artery Disease; Diabetes Mellitus, Type 1; Disease Progression; Female; Glycation End Products, Advanced; Glycosylation; Heart Diseases; Humans; Logistic Models; Lysine; Magnetic Resonance Imaging; Male; Multivariate Analysis; Odds Ratio; Pepsin A; Pyruvaldehyde; Risk Factors; Skin; Time Factors; Vascular Calcification; Young Adult | 2015 |
Altering dietary lysine:arginine ratio has little effect on cardiovascular risk factors and vascular reactivity in moderately hypercholesterolemic adults.
Topics: Adiponectin; Aged; Arginine; Blood Vessels; Cardiovascular Diseases; Cholesterol; Cross-Over Studies; Diet; Female; Humans; Hypercholesterolemia; Lysine; Male; Middle Aged; Phosphatidylcholine-Sterol O-Acyltransferase; Risk Factors | 2010 |
31 other study(ies) available for lysine and Cardiovascular Diseases
| Article | Year |
|---|---|
Comparison of serum metabolomics in women with breast Cancer Prior to Chemotherapy and at 1 year: cardiometabolic implications.
Topics: Amines; Amino Acids; Breast Neoplasms; Cardiovascular Diseases; Female; Humans; Lysine; Tandem Mass Spectrometry | 2023 |
Predisposition to atherosclerosis in children and adults with trisomy 21: biochemical and metabolomic studies.
Topics: Acetates; Adolescent; Adult; Apolipoprotein A-I; Apolipoproteins B; Atherosclerosis; Cardiovascular Diseases; Child; Creatinine; Down Syndrome; Formates; Glutamine; Humans; Lysine; Proline; Pyrrolidonecarboxylic Acid; Risk Factors; Xanthines | 2023 |
Epigenetic Quenching of VSMC Inflammation in CVD: H3K9me2 in Control.
Topics: Cardiovascular Diseases; Epigenesis, Genetic; Histones; Humans; Inflammation; Lysine; Muscle, Smooth, Vascular | 2019 |
Lysine pathway metabolites and the risk of type 2 diabetes and cardiovascular disease in the PREDIMED study: results from two case-cohort studies.
Topics: 2-Aminoadipic Acid; Aged; Aged, 80 and over; Biomarkers; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diet, Mediterranean; Female; Humans; Incidence; Lysine; Male; Middle Aged; Pipecolic Acids; Primary Prevention; Prospective Studies; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Risk Reduction Behavior; Time Factors; Treatment Outcome | 2019 |
Trimethyllysine and trimethylamine-N-oxide - pathogenic factors or surrogate markers of increased cardiovascular disease risk?
Topics: Biomarkers; Cardiovascular Diseases; Coronary Disease; Humans; Lysine; Methylamines; Myocardial Infarction; Oxides; Virulence Factors | 2020 |
Effect of arginine:lysine and glycine:methionine intake ratios on dyslipidemia and selected biomarkers implicated in cardiovascular disease: A study with hypercholesterolemic rats.
Topics: Administration, Oral; Amino Acids; Animals; Arginine; Biomarkers; Body Weight; Cardiovascular Diseases; Dyslipidemias; Glycine; Homocysteine; Hypercholesterolemia; Lipids; Liver; Lysine; Male; Methionine; Nitric Oxide; Organ Size; Rats, Wistar | 2017 |
Untargeted metabolomics identifies trimethyllysine, a TMAO-producing nutrient precursor, as a predictor of incident cardiovascular disease risk.
Topics: Aged; Animals; Atherosclerosis; Cardiovascular Diseases; Carnitine; Cholesterol; Choline; Disease Models, Animal; Feces; Female; Gastrointestinal Microbiome; Genome-Wide Association Study; Humans; Lysine; Male; Metabolomics; Methylamines; Mice; Mice, Inbred C57BL; Middle Aged; Nutrients; Risk Factors; Thrombosis | 2018 |
Methylglyoxal as a prognostic factor in patients with chronic kidney disease.
Topics: Aged; Arginine; Biomarkers; Cardiovascular Diseases; Deoxyglucose; Diabetic Nephropathies; Disease Progression; Female; Humans; Japan; Kidney Failure, Chronic; Lysine; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Pyruvaldehyde; Renal Insufficiency, Chronic; Risk Factors; Time Factors; Up-Regulation | 2019 |
Microbial metabolites as predictive biomarkers: a paradigm shift for cardiovascular risk stratification.
Topics: Acute Coronary Syndrome; Biomarkers; Cardiovascular Diseases; Humans; Lysine; Methylamines; Prognosis; Risk Factors | 2019 |
Establishment of reference values for the lysine acetylation marker N
Topics: Adolescent; Adult; Arginine; Biomarkers; Cardiovascular Diseases; Carnitine; Chromatography, Liquid; Citrulline; Creatinine; Female; Homoarginine; Humans; Lysine; Male; Middle Aged; Ornithine; Reference Values; Renal Insufficiency, Chronic; Tandem Mass Spectrometry; Young Adult | 2019 |
Plasma levels of advanced glycation endproducts Nε-(carboxymethyl)lysine, Nε-(carboxyethyl)lysine, and pentosidine are not independently associated with cardiovascular disease in individuals with or without type 2 diabetes: the Hoorn and CODAM studies.
Topics: Aged; Arginine; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Female; Glucose; Humans; Lysine; Male; Middle Aged | 2013 |
Serum carboxymethyl-lysine, disability, and frailty in older persons: the Cardiovascular Health Study.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Aging; Biomarkers; Cardiac Rehabilitation; Cardiovascular Diseases; Disabled Persons; Female; Follow-Up Studies; Frail Elderly; Health Status; Humans; Incidence; Lysine; Male; Prevalence; Prognosis; Retrospective Studies; United States | 2014 |
A novel ADIPOQ mutation (p.M40K) impairs assembly of high-molecular-weight adiponectin and is associated with early-onset obesity and metabolic syndrome.
Topics: Adiponectin; Adult; Age of Onset; Amino Acid Substitution; Cardiovascular Diseases; Case-Control Studies; Female; Humans; Lysine; Male; Metabolic Syndrome; Methionine; Middle Aged; Molecular Weight; Mutation, Missense; Obesity; Protein Multimerization; Young Adult | 2014 |
Advanced glycation/glycoxidation endproduct carboxymethyl-lysine and incidence of coronary heart disease and stroke in older adults.
Topics: Aged; Albumins; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Cohort Studies; Coronary Disease; Creatinine; Female; Glomerular Filtration Rate; Glycation End Products, Advanced; Humans; Immunoassay; Incidence; Lysine; Male; Oxidative Stress; Proportional Hazards Models; Stroke; Treatment Outcome | 2014 |
Serum carboxymethyl-lysine, an advanced glycation end product, is associated with arterial stiffness in older adults.
Topics: Aged; Aging; Aorta; Body Composition; Cardiovascular Diseases; Diabetes Mellitus; Female; Glycation End Products, Advanced; Humans; Hypertension; Inflammation; Linear Models; Lipoproteins, HDL; Logistic Models; Lysine; Male; Odds Ratio; Pulse Wave Analysis; Smoking; Vascular Stiffness | 2015 |
Skin Autofluorescence and Pentosidine Are Associated With Aortic Stiffening: The Maastricht Study.
Topics: Adult; Aged; Analysis of Variance; Arginine; Blood Pressure; Cardiovascular Diseases; Chi-Square Distribution; Cohort Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Glucose; Glycated Hemoglobin; Glycation End Products, Advanced; Humans; Linear Models; Lysine; Middle Aged; Optical Imaging; Prospective Studies; Pulse Wave Analysis; Skin; Vascular Stiffness | 2016 |
Advanced glycation end products and their circulating receptors predict cardiovascular disease mortality in older community-dwelling women.
Topics: Aged; Aging; Cardiovascular Diseases; Diabetes Mellitus; Female; Follow-Up Studies; Glycation End Products, Advanced; Humans; Lysine; Predictive Value of Tests; Prospective Studies; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Renal Insufficiency; Residence Characteristics; Risk Factors | 2009 |
Targeted metabolomic evaluation of arginine methylation and cardiovascular risks: potential mechanisms beyond nitric oxide synthase inhibition.
Topics: Aged; Arginine; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Citrulline; Coronary Artery Disease; Creatinine; Female; Humans; Lysine; Male; Metabolomics; Methylation; Middle Aged; Nitric Oxide Synthase; Odds Ratio; omega-N-Methylarginine; Ornithine; Prognosis; Prospective Studies; Protein Processing, Post-Translational; Risk Assessment; Risk Factors; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Time Factors | 2009 |
Selective inhibition of protein kinase C beta(2) attenuates inducible nitric oxide synthase-mediated cardiovascular abnormalities in streptozotocin-induced diabetic rats.
Topics: Animals; Aorta; Blood Glucose; Cardiovascular Diseases; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Enzyme Induction; Enzyme Inhibitors; Glucose; Indoles; Lysine; Male; Maleimides; Mannitol; Muscle, Smooth, Vascular; Myocytes, Cardiac; Nitric Oxide Synthase Type II; Protein Kinase C; Protein Kinase C beta; Rats; Rats, Wistar | 2009 |
Plasma carboxymethyl-lysine, an advanced glycation end product, and all-cause and cardiovascular disease mortality in older community-dwelling adults.
Topics: Aged; Aged, 80 and over; Cardiovascular Diseases; Cause of Death; Female; Glycation End Products, Advanced; Humans; Lysine; Male; Prospective Studies | 2009 |
Homocystamides promote free-radical and oxidative damage to proteins.
Topics: Alzheimer Disease; Cardiovascular Diseases; Congenital Abnormalities; Free Radicals; Homocysteine; Humans; Hydrogen Bonding; Kinetics; Lysine; Osteoporosis; Oxidative Stress; Protein Processing, Post-Translational; Renal Insufficiency; Serum Albumin | 2010 |
High plasma pentosidine level is accompanied with cardiovascular events in hemodialysis patients.
Topics: Aged; Arginine; C-Reactive Protein; Cardiovascular Diseases; Female; Glycation End Products, Advanced; Humans; Kaplan-Meier Estimate; Kidney Failure, Chronic; Lysine; Male; Middle Aged; Prognosis; Renal Dialysis; Risk | 2012 |
Are advanced glycation end products cardiovascular risk factors in patients with CRF?
Topics: Adult; Aged; Aged, 80 and over; Arginine; Cardiovascular Diseases; Diabetes Mellitus; Female; Glycation End Products, Advanced; Humans; Hypertrophy, Left Ventricular; Imidazoles; Kidney Failure, Chronic; Kidney Transplantation; Lysine; Male; Middle Aged; Renal Dialysis; Retrospective Studies; Risk Factors | 2003 |
Plasma pentosidine is associated with inflammation and malnutrition in end-stage renal disease patients starting on dialysis therapy.
Topics: Aged; Aged, 80 and over; Aging; Arginine; Cardiovascular Diseases; Cohort Studies; Female; Glomerular Filtration Rate; Humans; Inflammation; Kidney Failure, Chronic; Lysine; Male; Mortality; Nutrition Disorders; Prognosis; Prospective Studies; Renal Dialysis; Survival Analysis | 2003 |
Effect of smoking on risk factors for cardiovascular disease in patients with diabetes mellitus and renal insufficiency.
Topics: Adult; Aged; Arginine; Cardiovascular Diseases; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glycation End Products, Advanced; Homocysteine; Humans; Kidney Transplantation; Lysine; Middle Aged; Renal Dialysis; Renal Insufficiency; Risk Factors; Smoking | 2003 |
Advanced glycoxidation end products in commonly consumed foods.
Topics: Antibodies, Monoclonal; Cardiovascular Diseases; Cooking; Dietary Carbohydrates; Dietary Fats; Enzyme-Linked Immunosorbent Assay; Food Analysis; Food Handling; Glycation End Products, Advanced; Hot Temperature; Humans; Kidney Diseases; Lipid Peroxidation; Lysine; Maillard Reaction; Meat; Time Factors | 2004 |
High serum pentosidine concentrations are associated with increased arterial stiffness and thickness in patients with type 2 diabetes.
Topics: Aged; Analysis of Variance; Arginine; Arteries; Biomechanical Phenomena; Brachial Artery; Cardiovascular Diseases; Carotid Arteries; Diabetes Mellitus, Type 2; Female; Glycation End Products, Advanced; Humans; Linear Models; Lysine; Male; Middle Aged; Pulse; Tunica Intima; Tunica Media; Ultrasonography | 2005 |
Serum carboxymethyllysine predicts mortality in hemodialysis patients.
Topics: Adult; Cardiovascular Diseases; Female; Follow-Up Studies; Humans; Kidney Failure, Chronic; Lysine; Male; Middle Aged; Predictive Value of Tests; Renal Dialysis | 2006 |
[Is the serum concentration of pentosidine a predictor of cardiovascular events in patients with type 2 diabetes and kidney disease?].
Topics: Arginine; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Cohort Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glycation End Products, Advanced; Humans; Lipoproteins, LDL; Lysine; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Prospective Studies; Risk Factors; Time Factors | 2007 |
'Multipurpose oxidase' in atherogenesis.
Topics: Animals; Apoptosis; Atherosclerosis; Carbamates; Cardiovascular Diseases; Cell Proliferation; Citrulline; Endothelial Cells; Humans; Inflammation; Lipoproteins, HDL; Lipoproteins, LDL; Lysine; Macrophages; Mice; Models, Biological; Muscle, Smooth; Oxidation-Reduction; Peroxidase; Scavenger Receptors, Class A; Smoking; Substrate Specificity; Thiocyanates | 2007 |
Intercellular adhesion molecule 1 (ICAM1) Lys56Met and Gly241Arg gene variants, plasma-soluble ICAM1 concentrations, and risk of incident cardiovascular events in 23,014 initially healthy white women.
Topics: Aged; Arginine; Cardiovascular Diseases; Female; Genetic Variation; Genotype; Glycine; Humans; Intercellular Adhesion Molecule-1; Lysine; Methionine; Middle Aged; Prospective Studies; Risk Factors; White People | 2007 |